These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 24917141)
21. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in the Uygur population. Mayinu ; Chen X Mol Vis; 2011; 17():1734-44. PubMed ID: 21738402 [TBL] [Abstract][Full Text] [Related]
22. Variations in LOXL1 associated with exfoliation glaucoma do not affect amine oxidase activity. Kim S; Kim Y Mol Vis; 2012; 18():265-70. PubMed ID: 22328822 [TBL] [Abstract][Full Text] [Related]
24. Lack of association between lysyl oxidase-like 1 polymorphism in pseudoexfoliation syndrome and pseudoexfoliation glaucoma in North Indian population. Pandav SS; Chakma P; Khera A; Chugh N; Gupta PC; Thattaruthody F; Seth NG; Raj S; Kaushik S; Khullar M; Ram J Eur J Ophthalmol; 2019 Jul; 29(4):431-436. PubMed ID: 30189755 [TBL] [Abstract][Full Text] [Related]
25. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome. Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751 [TBL] [Abstract][Full Text] [Related]
26. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases. Anastasopoulos E; Founti P; Topouzis F Curr Opin Ophthalmol; 2015 Mar; 26(2):82-9. PubMed ID: 25594764 [TBL] [Abstract][Full Text] [Related]
27. Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations. Liu Y; Schmidt S; Qin X; Gibson J; Hutchins K; Santiago-Turla C; Wiggs JL; Budenz DL; Akafo S; Challa P; Herndon LW; Hauser MA; Allingham RR Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3465-8. PubMed ID: 18421074 [TBL] [Abstract][Full Text] [Related]
28. Association of Lysyl Oxidase-Like 1 Gene Polymorphisms in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma in a Spanish Population. de Juan-Marcos L; Escudero-Domínguez FA; Hernández-Galilea E; Cabrillo-Estévez L; Cruz-González F; Cieza-Borrella C; Sánchez-Barba M; González-Sarmiento R Ophthalmic Genet; 2016; 37(1):25-30. PubMed ID: 24892565 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of tear and aqueous humor level, and genetic variants of connective tissue growth factor as biomarkers for early detection of pseudoexfoliation syndrome/glaucoma. Can Demirdöğen B; Koçan Akçin C; Özge G; Mumcuoğlu T Exp Eye Res; 2019 Dec; 189():107837. PubMed ID: 31626800 [TBL] [Abstract][Full Text] [Related]
30. Lack of association between LOXL1 gene polymorphisms and primary open angle glaucoma in the Saudi Arabian population. Abu-Amero KK; Osman EA; Azad MT; Allingham RR; Hauser MA; Al-Obeidan SA Ophthalmic Genet; 2012 Sep; 33(3):130-3. PubMed ID: 21510775 [TBL] [Abstract][Full Text] [Related]
31. Association between polymorphisms in lysyl oxidase-like 1 and susceptibility to pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Tang JZ; Wang XQ; Ma HF; Wang B; Wang PF; Peng ZX; Zhou XY PLoS One; 2014; 9(3):e90331. PubMed ID: 24603551 [TBL] [Abstract][Full Text] [Related]
32. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma. Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114 [TBL] [Abstract][Full Text] [Related]
33. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations. Schlötzer-Schrehardt U Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397 [TBL] [Abstract][Full Text] [Related]
34. Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma. Rao KN; Ritch R; Dorairaj SK; Kaur I; Liebmann JM; Thomas R; Chakrabarti S Mol Vis; 2008 Jul; 14():1254-62. PubMed ID: 18618003 [TBL] [Abstract][Full Text] [Related]
35. Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Hayashi H; Gotoh N; Ueda Y; Nakanishi H; Yoshimura N Am J Ophthalmol; 2008 Mar; 145(3):582-585. PubMed ID: 18201684 [TBL] [Abstract][Full Text] [Related]
37. Association of LOXL1 gene with Finnish exfoliation syndrome patients. Lemmelä S; Forsman E; Onkamo P; Nurmi H; Laivuori H; Kivelä T; Puska P; Heger M; Eriksson A; Forsius H; Järvelä I J Hum Genet; 2009 May; 54(5):289-97. PubMed ID: 19343041 [TBL] [Abstract][Full Text] [Related]
38. Biological effect of LOXL1 coding variants associated with pseudoexfoliation syndrome. Sharma S; Martin S; Sykes MJ; Dave A; Hewitt AW; Burdon KP; Ronci M; Voelcker NH; Craig JE Exp Eye Res; 2016 May; 146():212-223. PubMed ID: 26997634 [TBL] [Abstract][Full Text] [Related]
39. Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells. Schmitt HM; Hake KM; Perkumas KM; Lê BM; Suarez MF; De Ieso ML; Rahman RS; Johnson WM; Gomez-Caraballo M; Ashley-Koch AE; Hauser MA; Stamer WD Hum Mol Genet; 2023 Oct; 32(21):3053-3062. PubMed ID: 37540217 [TBL] [Abstract][Full Text] [Related]
40. Ethnicity-based subgroup meta-analysis of the association of LOXL1 polymorphisms with glaucoma. Chen H; Chen LJ; Zhang M; Gong W; Tam PO; Lam DS; Pang CP Mol Vis; 2010 Feb; 16():167-77. PubMed ID: 20142848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]